Overview

Print Print page     Email Email page
TG Therapeutics, Inc. is a specialty healthcare product company focused on developing and commercializing innovative treatments for underserved patient populations.
Stock Information
OTCBB:TGTXD
$6.25   + 0.05
May 17, 2012
10:42 AM ET
Quotes delayed at least 20 minutes.
Information provided by eSignal.
Manhattan Pharmaceuticals Stock Chart
3 Mo.   6 Mo.   1 Yr.

Recent Releases

May 14, 2012
TG Therapeutics, Inc. Announces Investigational New Drug (IND) for TGTX-1101, Receives Clearance by the FDA to Commence Clinical Trials in the U.S.

Apr 27, 2012
Manhattan Pharmaceuticals, Inc. Announces Name Change to TG Therapeutics, Inc. and Reverse Stock Split

View all releases »

Events & Presentations

Oct 13, 2010 at 11:00 AM ET
Precision IR Biotech, Healthcare & Pharmaceutical Virtual Conference

May 20, 2008 at 7:40 AM ET
Manhattan Pharmaceuticals to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference

View all events & presentations »